For the Inventor, By the Inventor

Enter assignee name

Worcester, MA, United States of America

Advanced Cell Technology, Inc.

USPTO Granted Patents = 20

CIPO Patents = 3

EPO Patents = 2

Forward Citations = 315

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Robert P Lanza (11 out of 54 patents)

Irina V Klimanskaya (8 out of 24 patents)

Michael D West (7 out of 46 patents)

4. Young Gie Chung (5 out of 13 patents)

5. Jose Cibelli (4 out of 13 patents)

6. Karen B Chapman (4 out of 33 patents)

7. Raymond L Page (2 out of 3 patents)

8. Amy Burnside (2 out of 3 patents)

9. James M Robl (2 out of 24 patents)

10. Shi-Jiang Lu (1 out of 18 patents)

11. Hans R Schoeler (1 out of 2 patents)

12. Christopher Malcuit (1 out of 3 patents)

13. Tanja Dominko (1 out of 5 patents)

14. Roy Geoffrey Sargent (2 patents)

15. Hans Scholer (1 patent)

20 patents: Sort by Forward Citations

1. 10047340 - Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank (2018-08-14),

2. 9580683 - ES cell cytoplasm or ooplasm transfer to rejuventate recipient cells (2017-02-28),

3. 9334478 - Differentiating ES cells using a tenascin (2016-05-10),

4. 8796021 - Blastomere culture to produce mammalian embryonic stem cells (2014-08-05),

5. 8753884 - Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells (2014-06-17),

6. 8742200 - Derivation of embryonic stem cells and embryo-derived cells (2014-06-03),

7. 8642328 - Derivation of embryonic stem cells (2014-02-04),

8. 8597944 - Culture systems for ex vivo development (2013-12-03),

9. 8273571 - Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues (2012-09-25),

10. 8268303 - Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration (2012-09-18),

11. 8017393 - Hemangio-colony forming cells (2011-09-13),

12. 7951591 - Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues (2011-05-31),

13. 7910369 - Culture systems for ex vivo development (2011-03-22),

14. 7893315 - Derivation of embryonic stem cells and embryo-derived cells (2011-02-22),

15. 7838727 - Derivation of embryonic stem cells (2010-11-23),

Advanced Cell Technology, Inc. is a biotechnology company. Their website features information about their research and development of cellular therapies, specifically in the fields of regenerative medicine and stem cell technology. Advanced Cell Technology aims to create innovative treatments for various diseases, using the potential of human stem cells to repair and replace damaged cells in the body. Their dedication to scientific research and their cutting-edge technologies have positioned them as a leader in the field of regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

20 Patents

#16 in Worcester, MA

#939 in Massachusetts

#15,857 in US

#30,327 in the World

Worcester, MA, United States of America

Advanced Cell Technology, Inc.

Forward Citations = 315

13 inventors:

Robert P Lanza (11 out of 54 patents)

Irina V Klimanskaya (8 out of 24 patents)

Michael D West (7 out of 46 patents)

4. Young Gie Chung (5 out of 13 patents)

5. Jose Cibelli (4 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…